Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

Pharma Inc Hopes for Fair Deal

Business Standard

|

July 31, 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after US President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

- SANKET KOUL & SOHINI DAS

Trump on Wednesday called India's tariffs on US exports among the highest in the world, with the most strenuous non-monetary trade barriers of any country, in a post on Truth Social. He also warned of an unspecified penalty on India over the 25 per cent tariff for buying Russian military equipment and energy.

FLERE HISTORIER FRA Business Standard

Business Standard

Business Standard

‘Investor awareness becomes more important than ever’

Ananth Narayan G describes his three-year tenure as whole-time member of the Securities and Exchange Board of India (Sebi) as a privilege that allowed him to make an impact on a larger canvas.

time to read

3 mins

November 01, 2025

Business Standard

Business Standard

New currency of hard power

If China is an exporting superpower, America is an importing one. Mr Trump has turned what would usually be a liability into an asset

time to read

5 mins

November 01, 2025

Business Standard

Business Standard

Apple's India revenue hits new high in Sep qtr

Apple set an all-time revenue record in India for the September quarter, driven by strong iPhone sales, as the American technology giant’s overall sales revenue reached $102.5 billion globally.

time to read

1 mins

November 01, 2025

Business Standard

Business Standard

USFDA's new biosimilar norms to woo more players, fast-track mkt entry

The US Food and Drug Administration’s (USEDA)'s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars — lower-priced, near-replicas of complex biologic medicines — could significantly benefit Indian biotech companies.

time to read

2 mins

November 01, 2025

Business Standard

Business Standard

Apple revenue tops $100 bn for first time

iPhone price hike drives record quarter

time to read

1 mins

November 01, 2025

Business Standard

Business Standard

Vedanta net profit plunges 59% on exceptional losses

Mining major Vedanta’s consolidated net profit plunged 58.69 per cent year-on-year (Y-0-Y) to %1,798 crore inthe second quarter of 2025-26 (Q2FY26), dragged down by exceptional losses booked during the period under review. The company had reported anet exceptional gain of $1,160 crore in Q2FY25.

time to read

2 mins

November 01, 2025

Business Standard

Sebi chief stresses responsible tech use, stronger market resilience

The Securities and Exchange Board of India (Sebi) is promoting the responsible use of emerging technologies, such as artificial intelligence in financial markets, strengthening cybersecurity, and preparing entities for change, said Chairman Tuhin Kanta Pandey on Friday.

time to read

1 mins

November 01, 2025

Business Standard

Business Standard

Private investment, states key to achieving Viksit Bharat goal: EAC-PM chairman

Stronger private investment and active role of states are key to sustaining India’s growth momentum and taking the country towards the Viksit Bharat 2047 goal, S Mahendra Dev, the chairman of the Economic Advisory Council to the Prime Minister (EAC-PM) said on Friday.

time to read

1 mins

November 01, 2025

Business Standard

Business Standard

'FPIs believe in India's long-term growth story'

For Securities and Exchange Board of India (Sebi) Chairman Tuhin Kanta Pandey, trust is the cornerstone of India's fast-expanding capital markets - and it must be earned every day through action, not announcement. In a fireside chat with Tamal Bandyopadhyay, he talks of various aspects of Sebi's functioning. Edited excerpts:

time to read

5 mins

November 01, 2025

Business Standard

Ford to revive Chennai plant to produce 'nextgen' engines

US AUTO GIANT SIGNS ₹3,250 CRORE MOU WITH TAMIL NADU GOVERNMENT; MANUFACTURING FOR EXPORTS TO BEGIN IN 2029

time to read

2 mins

November 01, 2025

Listen

Translate

Share

-
+

Change font size